PRI Responds to CMS Adding 15 Additional Drugs That Will Be Subjected to Government Price Controls
Sally Pipes and Wayne Winegarden | January 17, 2025
Reforms Can Improve Competition and Generate More Savings
Wayne Winegarden | January 7, 2025
Medicare should cover anti-obesity drugs
Sally Pipes | January 6, 2025
Despite Achievements, Barriers That Discourage Biosimilar Use Remain
Wayne Winegarden | December 2, 2024
PRI Files Amicus Brief in Key State Supreme Court Case That Could Upend Future Medical Innovation in California
Pacific Research Institute | November 7, 2024
Low-Cost Biosimilars Are Saving Billions, Potential Savings Are Even Greater
Wayne Winegarden | October 28, 2024
Trump vs. Harris on Health Care: Experts Explain Each Side
Wayne Winegarden | October 23, 2024
Read the latest on healthcare policies and drug pricing
Click here to see a full library of the Drug Pricing Maze series videos.
Latest Multimedia
Watch the first video from the Coverage Denies series.
Areas of Research
The Center’s mission is to research and advance policies that support the continued viability and vitality of the U.S. biomedical and pharmaceutical industries to the benefit of patients and overall economic growth.